STAND. COM. REP. 2380

Honolulu, Hawaii

, 2004

RE: S.B. No. 2950

S.D. 1

 

 

Honorable Robert Bunda

President of the Senate

Twenty-Second State Legislature

Regular Session of 2004

State of Hawaii

Sir:

Your Committee on Health, to which was referred S.B. No. 2950 entitled:

"A BILL FOR AN ACT RELATING TO GENERIC SUBSTITUTION OF PRESCRIPTION DRUG PRODUCTS,"

begs leave to report as follows:

The purpose of this measure is to make USFDA approved, therapeutically equivalent generic drug products substitutable upon approval by the Director of Health.

Your Committee received testimony in support of the measure from the Department of Health, Kaiser Permanente, and Hawaii Medical Service Association.

Your Committee finds that this measure will expedite the public's access to safe, low-cost drug products.

Your Committee made technical nonsubstantive amendments to comport with preferred drafting style.

As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2950, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2950, S.D. 1, and be referred to the Committee on Commerce, Consumer Protection and Housing.

Respectfully submitted on behalf of the members of the Committee on Health,

____________________________

ROSALYN H. BAKER, Chair